Table 2. Univariate and multivariate regression analyses of poor medication adherence over the past 2 months of the COVID-19 pandemic.
| Variable | Univariate analysis | Multivariate analysis | |||||
|---|---|---|---|---|---|---|---|
| OR | 95% CI | P value | OR | 95% CI | P value | ||
| Age | 0.897 | 0.334–2.408 | 0.830 | – | – | NS | |
| Sex | 0.667 | 0.179–2.479 | 0.545 | – | – | NS | |
| Combined medication | 0.350 | 0.125–0.979 | 0.046 | 0.258 | 0.079–0.842 | 0.025 | |
| Inhalation <45 months | 2.778 | 0.994–7.766 | 0.051 | – | – | NS | |
| No continuous doctor supervision | 3.531 | 1.284–9.708 | 0.015 | 5.390 | 1.671–17.381 | 0.005 | |
| Low risk | 0.278 | 0.094–0.823 | 0.021 | – | – | NS | |
| Exacerbation in 2019 | 3.600 | 1.215–10.669 | 0.021 | – | – | NS | |
| Possible depression | 3.133 | 1.132–8.672 | 0.028 | 3.691 | 1.187–11.480 | 0.024 | |
OR, odds ratio; CI, confidence interval; NS, no significant difference.